Quarterly Net Profit at Rs. 16.29 crore in March 2025 down 3.92% from Rs. 16.95 crore in March 2024. EBITDA stands at Rs.

Windlas Biotech Ltd has lost 9.89% over last one month compared to 1.44% fall in BSE Healthcare index and 1.1% rise in the SENSEX ...

Retail buzz around Imunon rose sharply Thursday after the clinical-stage biotech company said it will no longer pursue a ...

The investment round, valued at close to 100 million renminbi, or $13.8 million, was led by L'Oréal's China fund, its ...

President Trump on Thursday claimed his recent “most favored nation” executive order could cause U.S. drug prices to “drop like a rock” in just a matter of weeks, saying ...

Rapper Kid Cudi told a jury Sean "Diddy" Combs broke into his Los Angeles home after the hip-hop mogul found out he was ...

STAT reporters chat about the mood in the gene editing field, M&A deals in biotech, and leadership changes at Novo Nordisk.

Wexner, who is chairman of the board and for whom the medical center is named, said that "probably the largest AI investment in the world will happen in Columbus" and predicted that "100 more" medical ...

Already a Vigil Neuroscience investor, Sanofi has agreed to buy the rest of the biotech’s shares for $8 apiece, representing a total deal value of $470 million.

The Beachwood-based company announced on Tuesday, May 20, that it has appointed Dr. David Llewellyn as its new CEO and as a ...

The Trump administration has revoked a $44 million dollar grant intended for the Birmingham area to bolster Biotechnology ...

Fore Biotherapeutics is seeking another $8 million in late-stage funding. Philadelphia biotechnology firm names former ...